These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21907911)

  • 1. Biological and pharmacological roles of HCA receptors.
    Blad CC; Ahmed K; IJzerman AP; Offermanns S
    Adv Pharmacol; 2011; 62():219-50. PubMed ID: 21907911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B).
    Offermanns S; Colletti SL; Lovenberg TW; Semple G; Wise A; IJzerman AP
    Pharmacol Rev; 2011 Jun; 63(2):269-90. PubMed ID: 21454438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological roles and therapeutic potential of hydroxy-carboxylic Acid receptors.
    Ahmed K
    Front Endocrinol (Lausanne); 2011; 2():51. PubMed ID: 22654812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic acid receptor subtypes and their ligands.
    Soudijn W; van Wijngaarden I; Ijzerman AP
    Med Res Rev; 2007 May; 27(3):417-33. PubMed ID: 17238156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors.
    Ahmed K; Tunaru S; Offermanns S
    Trends Pharmacol Sci; 2009 Nov; 30(11):557-62. PubMed ID: 19837462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of HCA₂ (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin.
    Hanson J; Gille A; Offermanns S
    Pharmacol Ther; 2012 Oct; 136(1):1-7. PubMed ID: 22743741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxy-Carboxylic Acid Receptor Actions in Metabolism.
    Offermanns S
    Trends Endocrinol Metab; 2017 Mar; 28(3):227-236. PubMed ID: 28087125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G).
    Tunaru S; Lättig J; Kero J; Krause G; Offermanns S
    Mol Pharmacol; 2005 Nov; 68(5):1271-80. PubMed ID: 16099840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future of GPR109A agonists in the treatment of dyslipidaemia.
    Wanders D; Judd RL
    Diabetes Obes Metab; 2011 Aug; 13(8):685-91. PubMed ID: 21418500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors.
    Offermanns S
    Annu Rev Pharmacol Toxicol; 2014; 54():407-34. PubMed ID: 24160702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2007 Dec; 100(11 A):S53-61. PubMed ID: 18047854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109b.
    Semple G; Skinner PJ; Cherrier MC; Webb PJ; Sage CR; Tamura SY; Chen R; Richman JG; Connolly DT
    J Med Chem; 2006 Feb; 49(4):1227-30. PubMed ID: 16480258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.
    Benyó Z; Gille A; Kero J; Csiky M; Suchánková MC; Nüsing RM; Moers A; Pfeffer K; Offermanns S
    J Clin Invest; 2005 Dec; 115(12):3634-40. PubMed ID: 16322797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target.
    Offermanns S
    Trends Pharmacol Sci; 2006 Jul; 27(7):384-90. PubMed ID: 16766048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride modulation by acifran analogs: activity towards the niacin high and low affinity G protein-coupled receptors HM74A and HM74.
    Mahboubi K; Witman-Jones T; Adamus JE; Letsinger JT; Whitehouse D; Moorman AR; Sawicki D; Bergenhem N; Ross SA
    Biochem Biophys Res Commun; 2006 Feb; 340(2):482-90. PubMed ID: 16389067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis.
    Ahmed K; Tunaru S; Langhans CD; Hanson J; Michalski CW; Kölker S; Jones PM; Okun JG; Offermanns S
    J Biol Chem; 2009 Aug; 284(33):21928-21933. PubMed ID: 19561068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impedance measurement: a new method to detect ligand-biased receptor signaling.
    Kammermann M; Denelavas A; Imbach A; Grether U; Dehmlow H; Apfel CM; Hertel C
    Biochem Biophys Res Commun; 2011 Sep; 412(3):419-24. PubMed ID: 21827738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials.
    Lukasova M; Hanson J; Tunaru S; Offermanns S
    Trends Pharmacol Sci; 2011 Dec; 32(12):700-7. PubMed ID: 21944259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of arachidonic acid signaling pathway by nicotinic acid receptor HM74A.
    Tang Y; Zhou L; Gunnet JW; Wines PG; Cryan EV; Demarest KT
    Biochem Biophys Res Commun; 2006 Jun; 345(1):29-37. PubMed ID: 16674924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.